Latest multiple sclerosis Stories
MISSISSAUGA, ON, June 25, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in British Columbia (B.C.) through B.C.
The Conrad N.
Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass.,
The Pharmaceutical Care Management Association (PCMA) today released a new ad campaign in New York — “I’m Not Willing to Send My Patients to Just Any Pharmacy” — that highlights how
NEWPORT BEACH, Calif., June 11, 2014 /PRNewswire/ -- A new study sheds light on the positive effect of a venous procedure upon the sympathetic nervous system.
DailyGossip.org publishes a complex review to a new method of curing multiple sclerosis.
CHERRY HILL, N.J., June 5, 2014 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is pleased to announce that the newly published
A new data standard for multiple sclerosis (MS) has been released by the Clinical Data Interchange Standards Consortium (CDISC), the leading global standards organization for clinical research.
The 2014 LDN at the MEET is being organised by the charity the LDN Research Trust in the UK and Mark’s Dugs in the US.
Researchmoz presents this most up-to-date research on "EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2023".
More Images (1 images) »